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Methylglyoxal induces apoptosis through activation of p38 mi- (AGEs) were shown to be localized in the glomeruli of
togen-activated protein kinase in rat mesangial cells. diabetic subjects [1–3]. It is also known that dicarbonyl
Background. The formation of methylglyoxal (MG), a intermediates such as 3-deoxyglucosone (3-DG) andhighly reactive dicarbonyl compound, is accelerated through
methylglyoxal (MG) are potent precursors of AGEsseveral pathways, including the glycation reaction under dia-
[4–9]. In fact, formation of both 3-DG and MG are re-betic conditions, presumably contributing to tissue injury in
diabetes. On the other hand, apoptotic cell death of glomerular ported to be accelerated in diabetic subjects [9–14]. Re-
cells has been suggested to play a role in the development of cent studies have suggested that these dicarbonyl com-
glomerulosclerosis in various types of glomerular injuries. We pounds by themselves play a role in the pathogenesis oftherefore examined whether MG was capable of inducing apo-
cellular dysfunction related to diabetic complications.ptosis in rat mesangial cells to address the possible mechanism
Dicarbonyl compounds are highly reactive and are knownby which hyperglycemia-related products accelerated patho-
logic changes in diabetic glomerulosclerosis. to modulate the structure and function of intracellular
Methods. Rat mesangial cells were incubated with 0 to 400 proteins [15, 16]. However, involvement of the dicarbo-
mol/L MG, followed by the detection of apoptosis by both nyl compounds in the development of diabetic nephropa-TUNEL method and electrophoretic analysis for DNA frag-
thy has not been fully investigated.mentation. In addition, we investigated intracellular mecha-
Glomerular mesangial cells play a central role in thenisms mediating MG-induced apoptosis, focusing especially on
the p38 mitogen-activated protein kinase (MAPK) pathway. pathogenesis of diabetic nephropathy. One of the charac-
Results. MG induced apoptosis in rat mesangial cells in a teristic pathologic changes in diabetic nephropathy is
dose-dependent manner and was accompanied by the activa-
the accumulation of extracellular matrix (ECM) in thetion of p38 isoform. Aminoguanidine and N-acetyl-l-cysteine
glomeruli. The ECM proteins are mainly produced byinhibited the MG-induced p38 MAPK activation, as well as
apoptosis in rat mesangial cells, suggesting the involvement mesangial cells [17, 18]. In addition, loss of glomerular
of oxidative stress in these phenomena. SB203580, a specific cellular components such as mesangial cells is character-
inhibitor of p38 MAPK also suppressed the MG-induced apo- istic of the advanced stages of glomerulosclerosis [19, 20].
ptosis in rat mesangial cells.
However, the precise mechanism for the decrease in cellConclusions. These results suggest a potential role for MG in
number in diabetic glomeruli remains unclear. In thisglomerular injury through p38 MAPK activation under diabetic
conditions and may serve as a novel insight into the therapeutic regard, the involvement of apoptosis has been demon-
strategies for diabetic nephropathy. strated in various types of glomerular injuries, including
both experimental models and in human glomerulo-
nephritis [21–24]. We therefore investigated whether
The implication of the glycation reaction in the patho- high glucose–related conditions may induce apoptosis in
genesis of diabetic nephropathy has been proposed, ever mesangial cells, especially by focusing on the action of
since several kinds of advanced glycation end products MG, to shed light on the potential mechanism leading
to the loss of glomerular cells during the development
of diabetic glomerulosclerosis.Key words: methylglyoxal, mesangial cells, apoptosis, glycation, p38
MAPK, diabetic nephropathy. In addition, we attempted to clarify the intracellular
mechanism responsible for the MG-induced apoptosis inReceived for publication July 7, 2002
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JNK and p38 MAPK are representative members of this tion by using medium A that had been in advance pre-
incubated with 400 mol/L MG at 37C for 4 hours andfamily and are involved in the regulation of survival and
apoptotic death of the cells [25–30]. With reference to subjected to ultrafiltration through Centricut mini filter
(molecular mass cutoff 10 kD, Kurabou Co. Ltd., Osaka,diabetic conditions, several lines of evidence have shown
that p38 MAPK are activated in the cells cultured under Japan) to remove free MG. For the inhibition experi-
ments, the certain cells were incubated with 400 mol/Lhigh glucose conditions [31–32]. Furthermore, the activa-
tion of p38 MAPK was also observed in glomeruli of MG in the presence and absence of 100 to 400 mol/L
aminoguanidine (AG), a glycation inhibitor. In addition,diabetic rats [33–34]. These findings led us to focus on
the involvement of the p38 MAPK pathway in an effort we examined the effects of 0.2 to 20 mmol/L N-acetyl-
l-cysteine, an antioxidant, and 0.1 to 10mol/L SB203580,to elucidate the intracellular molecular mechanisms re-
sponsible for MG-induced apoptosis. a specific p38 MAPK inhibitor, on MG-induced apopto-
sis and activation of the p38 MAPK pathway by the
pretreatment of rat mesangial cells with these agents for
METHODS
0.5 hour and 1 hour, respectively. SB202474 was used as
Materials a negative control against p38 MAPK inhibitor.
Trypsin-ethylenediaminetetraacetic acid (EDTA), Dul-
Detection of apoptotic cells by TUNEL methodbecco’s modified Eagle’s medium (DMEM) containing
1 g/L glucose, penicillin/streptomycin, and 123 bp DNA Rat mesangial cells were seeded on the coverslip in
12-well plates and incubated with MG in the presenceladder marker were purchased from GIBCO, BRL (Rock-
ville, MD, USA). Fetal calf serum (FCS) was purchased and absence of the inhibitors as described above at 37C
for 4 hours and 16 hours. The cells were then fixed in 4%from the JRH Biosciences CSL Company (Lenexa, KS,
USA). MG and aminoguanidine were purchased from paraformaldehyde in phosphate buffer (pH 7.4) at room
temperature for 30 minutes. Apoptotic cells were detectedSigma Chemical Company (St. Louis, MO, USA). N-acetyl-
l-cysteine and 4% paraformaldehyde were purchased by the terminal deoxynucleotidyl transferase-mediated
uridine triphosphate nick end labeling (TUNEL) methodfrom Nacalai Tasque, Inc. (Tokyo, Japan). SB203580 and
SB202474 were purchased from Calbiochem-Novabio- using an in situ Apoptosis Detection Kit (TaKaRa Bio-
medicals, Shiga, Japan) according to the manufacturer’schem Corporation (San Diego, CA, USA). Anti-p38
MAPK rabbit polyclonal antibody and anti-p38 goat protocol [37].
polyclonal antibody were purchased from Santa Cruz
Electrophoretic analysis for DNA fragmentationBiotechnology, Inc. (Santa Cruz, CA, USA). The former
is known to recognize the  isoform of p38 MAPK. Rat mesangial cells, in 15 cm culture dishes, were incu-
bated with MG in the presence and absence of the inhibi-All other chemicals were also of analytical grade and
purchased from Wako Pure Chemical Industries, Ltd. tors as described above, at 37C for 8 hours. This was
followed by selective extraction of fragmented DNA(Osaka, Japan), unless otherwise noted
from the cells with ApopLadder EX kit (TaKaRa Bio-
Cell culture medicals) according to the manufacturer’s protocol. The
extracted DNA was then electrophoretically analyzedRat mesangial cells were obtained from the glomeruli
of renal cortex isolated from male Sprague-Dawley rats using a 2% agarose gel containing ethidium bromide.
(CLEA Japan, Inc., Osaka, Japan), as described else-
Immunoblot analysis for phosphorylationwhere [35, 36]. The cells were maintained in DMEM
of MKK3/MKK6supplemented with 17% FCS, 100 U/mL penicillin, and
100 g/mL streptomycin at 37C in a 5% carbon dioxide Initially, in order to investigate the involvement of the
p38 MAPK pathway in the MG-induced apoptosis, we(CO2) atmosphere. Passages between four and six were
used for the following experiments. examined whether MG induced phosphorylation of
MKK3/MKK6, an upstream molecule of p38 MAPK. In
Experimental conditions of cells brief, rat mesangial cells in 6-well plates were treated
with 400 mol/L of MG for 0 to 4 hours, washed withWhen rat mesangial cells reached approximately 80%
confluency, they were starved in DMEM with 1% FCS ice-cold PBS, and then lysed in 100L of sodium dodecyl
sulfate (SDS) sample buffer [62.5 mmol/L Tris-HCl (pH(medium A) for 2 days, followed by two washes in phos-
phate-buffered saline (PBS). To examine the effects of 6.8), 2% mol/L SDS, 10% glycerol, 50 mmol/L dithi-
othreitol, and 0.1% bromphenol blue]. Cell lysates wereMG on the induction of apoptosis and activation of p38
MAPK pathway, the cells were incubated with 0 to 400 passed through 21-gauge needles on ice several times
and were then electrophoresed on a 10% SDS-polyacryl-mol/L MG in medium A for the indicated periods in
each experiment. In addition, we examined the effect of amide gel (SDS-PAGE). Subsequently, the separated
protein bands were transferred onto a nitrocelluloseMG-modified serum proteins formed during the incuba-
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membrane and subjected to immunoblot analysis with antiphospho-p38 MAPK antibody, recognizing the phos-
phorylated forms of both  and  isoforms.anti-MKK3/MKK6 antibody and antiphospho-MKK3/
MKK6 (Ser189/207) as primary antibodies using a Phos-
phoPlus MKK3/MKK6 (Ser189/207) Kit (Cell Signaling
RESULTS
Technology, Inc., Beverly, MA, USA). In addition, we
TUNEL analysis in rat mesangial cellsinvestigated the dose response of MG and effects of the
inhibitors on MG-induced phosphorylation of MKK3/ The TUNEL-positive cells significantly increased after
4 hours of the incubation with MG at the concentrationMKK6 in the cell treatments described above at the
incubation period of 0.5 hour. In the present study, all of more than 200 mol/L in a dose-dependent manner
(Fig. 1). The positive cells revealed morphologic changesthe positive bands were visualized by a chemiluminescent
detection system. characteristic for apoptotic cells, such as discrete clump-
ing and condensation of the chromatin. In particular, the
Immunoblot analysis for phosphorylation of cells incubated with 400 mol/L MG showed marked
p38 MAPK formation of small apoptotic bodies (Fig. 1E). Since the
cells in the medium preincubated with 400 mol/L MGRat mesangial cells in 6-well plates were treated with
100 or 400 mol/L MG for 0 to 4 hours to examine prior to the experiment showed little apoptosis (Fig. 1F),
an effect of MG-modified serum proteins formed duringwhether MG induced phosphorylation of p38 MAPK.
Immunoblot analysis was carried out using PhosphoPlus the incubation seemed not essential. On the other hand,
the cells exposed to 100 mol/L MG for 4 hours showedp38 MAP Kinase (Thr180/Tyr182) Antibody Kit (Cell
Signaling Technology, Inc.). The method was the same little change (Fig. 1C). However, prolonged exposure of
rat mesangial cells, even at 100 mol/L MG, led to anas that described for MKK3/MKK6 except that the anti-
p38 MAP kinase and antiphospho-p38 MAP kinase increase of TUNEL-positive cells, so that the number
of the positive cells became significantly (P  0.05)(Thy180/Tyr182) antibodies were used as primary anti-
bodies. The dose response of MG and effects of the inhibi- greater than that of the untreated cells (Fig. 2). The
cellular alterations induced by 400 mol/L MG weretors on MG-induced phosphorylation of p38 MAPK in
the cells were also assessed after an incubation period significantly suppressed when the cells were treated with
inhibitors such as 400 mol/L AG, 20 mmol/L N-acetyl-of 1 hour.
l-cysteine, and 10 mol/L SB203580 (Fig. 3). On the
Activity of p38 MAPK other hand, the cells pretreated with SB202474, as a
negative control against p38 MAPK inhibitor, failed toRat mesangial cells in 15 cm dishes were treated with
400 mol/L MG for 0 to 4 hours and lyzed in ice-cold cell inhibit the morphologic changes caused by exposure to
400 mol/L MG (Fig. 3E).lysis buffer [20 mmol/L Tris (pH 7.5), 150 mmol/L NaCl,
1 mmol/L EDTA, 1 mmol/L ethylene glycol bis(-amino-
Effects of MG on DNA fragmentationethyl ether)N,N,N,Ntetraacetic acid) (EGTA), 1% Tri-
ton X-100, 2.5 mmol/L sodium pyrophosphate, 1 mmol/L The occurrence of apoptosis in rat mesangial cells was
confirmed by the detection of DNA ladders, a hallmark-glycerolphosphate, 1 mmol/L Na3VO4, 1g/mL leupep-
tin, and 1 mmol/L phenylmethylsulfonyl fluoride (PMSF)]. of apoptotic cell death. Rat mesangial cells incubated
with MG, at concentrations of more than 200 mol/L,This was followed by an assessment of p38 MAPK activ-
ity using p38 MAP Kinase Assay Kit (Cell Signaling showed apparent DNA ladders after 8 hours (Fig. 4A).
After prolonged (24 hours) exposure, the DNA laddersTechnology, Inc.) as described elsewhere [38]. The activ-
ity of p38 MAPK in each cell lysate was assessed by its from rat mesangial cells incubated with 100 mol/L MG
also became appreciable (data not shown). The DNAability to phosphorylate exogenously added 2 g intact
activating transcription factor-2 (ATF-2), a substrate of fragmentation induced by the incubation with 400 mol/L
of MG for 8 hours was inhibited by AG (Fig. 4B), N-acetyl-p38 MAPK, which was then detected by immunoblotting
with antiphospho-ATF-2 antibody. l-cysteine (Fig. 4C), and by SB203580 (Fig. 4D), all in
a dose-dependent manner.
Phosphorylation of p38 MAPK isoforms
Phosphorylation of MKK3/MKK6 by MGLysates of the cells were prepared after the incubation
with MG as described above. Each cell lysate was immu- Immunoblot analysis using antiphospho MKK3/MKK6
antibody showed that the phosphorylation of MKK3/noprecipitated with anti-p38 antibody or anti-p38 an-
tibody as described elsewhere [39]. Pellets were loaded MKK6 in rat mesangial cells was induced by incubation
with 400 mol/L MG and reached peak at 0.5 hour,on 10% SDS-PAGE, followed by immunoblot analysis
using anti-p38 antibody or anti-p38 antibody. The ex- while the protein content of MKK3/MKK6 itself was not
changed during the same period (Fig. 5A). This phos-tent of phosphorylation of these p38 MAPK isoforms
was simultaneously evaluated by immunoblotting with phorylation was detectable even in the cells incubated
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Fig. 2. Apoptosis in rat mesangial cells induced by incubation with
methylglyoxal (MG) for 16 hours. Rat mesangial cells were incubated
with 0 (A), 50 (B), 100 (C), and 200mol/L (D) MG for 16 hours, followed
by terminal deoxynucleotidyl transferase-mediated uridine triphosphate
nick end labeling (TUNEL) analysis. The number of TUNEL-positive
cells in rat mesangial cells incubated with concentrations of MG as low
as 100 mol/L became significantly higher than those found in cells
incubated without MG for a longer incubation. (E) The positive cells
were counted in six different fields under the fluorescent microscope
(630). Bars represent the mean  SD of the number of positive cells
per field. Data were analyzed by one-way ANOVA followed by DunnettFig. 1. Apoptosis in rat mesangial cells induced by incubation with multiple comparison test. The results are representative of three sepa-methylglyoxal (MG) for 4 hours. Rat mesangial cells were incubated rate experiments. *P  0.05; **P  0.01 vs. 0 mol/L MG.with 0 (A), 50 (B), 100 (C ), 200 (D), and 400 mol/L (E ) MG for
4 hours, followed by terminal deoxynucleotidyl transferase-mediated
uridine triphosphate nick end labeling (TUNEL) analysis. MG induced
apoptosis in rat mesangial cells in a dose-dependent manner. Cells incu-
bated with 400mol/L MG showed marked formation of small apoptotic Phosphorylation of p38 MAPK by MG
bodies. (F ) MG-modified serum proteins prepared by incubating me-
dium containing 1% fetal calf serum (FCS) with 400 mol/L MG for The rat mesangial cells treated with 400 mol/L MG
4 hours prior to the experiment induced little apoptosis. (G) The positive showed phosphorylation of p38 MAPK within 0.5 hour.
cells were counted in six different fields under the fluorescent micro-
Peak phosphorylation activity occurred 1 hour after thescope (630). Bars represent the mean  SD of the number of positive
cells per field. Data were analyzed by one-way ANOVA followed by initiation of stimulation without a change in protein con-
Dunnett multiple comparison test. The results are representative of tent (Fig. 6A). The MG-induced phosphorylation of p38
three separate experiments. *P  0.01 vs. 0 mol/L MG.
MAPK at 1 hour occurred in a dose-dependent manner
of MG (Fig. 6B). This phosphorylation, induced by 400with 100 mol/L MG for 0.5 hour and became more
mol/L MG, was inhibited by AG (Fig. 6B), and N-acetyl-prominent at the higher concentrations of MG (Fig. 5B).
l-cysteine (Fig. 6C). SB203580 was confirmed to inhibitFurthermore, this phosphorylation induced by 400mol/L
this MG-induced phosphorylation of p38 MAPK, whileMG was in part inhibited by AG (Fig. 5C) and N-acetyl-
l-cysteine (Fig. 5D) in dose-dependent manners. SB202474, a negative control, failed to cause inhibition
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Fig. 4. DNA fragmentation induced by methylglyoxal (MG) in rat
mesangial cells. Rat mesangial cells were treated with MG (0 to 400
mol/L) for 8 hours (A), followed by electrophoretical detection of
nucleosomal DNA fragmentation (DNA ladder) with 2% agarose gel.
DNA ladders were apparent in rat mesangial cells incubated with MG
at concentrations of more than 200 mol/L for 8 hours. The DNA
fragmentation induced by the treatment with 400 mol/L MG was
suppressed by aminoguanidine (AG) (B), N-acetyl-l-cysteine (NAC)
(C ), and SB203580 (D) in dose-dependent manners.
Activation of p38 MAPK by MG
Immunocomplex kinase assay for p38 MAPK showed
an increase in its activity in rat mesangial cells incubated
with 400 mol/L MG and peak activity was observed at
2 hours (Fig. 7A). This MG-induced activation of p38
Fig. 3. Effects of inhibitors on methylglyoxal (MG)-induced apoptosis MAPK at 2 hours occurred in a dose-dependent manner
in rat mesangial cells. Rat mesangial cells were incubated for 4 hours
(Fig. 7B). Furthermore, the MG-induced activation of p38with 400 mol/L MG in the absence (A) and presence (B) of aminogua-
nidine (AG, 400 mol/L), a glycation inhibitor. Inhibitory effects of MAPK by 400 mol/L MG was inhibited by AG (Fig.
pretreatment of cells with 20 mmol/L N-acetyl-l-cysteine (NAC) (C ), 7B), N-acetyl-l-cysteine (Fig. 7C), and SB203580 (Fig.
an antioxidant, and 10 mol/L SB203580 (D), a specific inhibitor of
7D) in dose-dependent manners.p38 mitogen-activated protein kinase (MAPK), on the apoptosis in the
cells incubated with 400 mol/L MG for 4 hours were investigated. (E)
In addition, an effect of SB202474, a negative control against SB203580 Isoform-dependent phosphorylation of p38 MAPK
was also examined. (F) The terminal deoxynucleotidyl transferase-medi-
Immunoblot analysis for the phosphorylation of p38ated uridine triphosphate nick end labeling (TUNEL)–positive cells
were counted in six different fields under the fluorescent microscope isoforms revealed that p38 was a predominant isoform
(630). Bars represent the mean  SD of the number of positive cells to be phosphorylated in rat mesangial cells by treatmentper field. Data were analyzed by one-way ANOVA followed by Dunnett
with MG (Fig. 8). In addition, the phosphorylation ofmultiple comparison test. The results are representative of three sepa-
rate experiments. *P  0.001 vs. 400 mol/L MG alone. p38 isoform was proved to be inhibited by AG, N-acetyl-
l-cysteine, and SB203580 (Fig. 8A). On the other hand,
p38 isoform was phosphorylated by MG treatment to
a much lesser extent (Fig. 8B).
(Fig. 6D). In addition, we examined a time-course of
DISCUSSIONp38 MAPK phosphorylation in response to 100 mol/L
The present study indicated that MG induced apopto-MG (Fig. 6E), indicating that the lower dose of MG also
sis in rat mesangial cells in a dose-dependent manner.phosphorylated p38 MAPK. However, the phosphoryla-
Formation of MG is accelerated under diabetic condi-tion by 100 mol/L MG was diminished earlier after
tions due to hyperglycemia-related metabolism [11–14],the peak (0.5 hour), compared with the time-course in
response to 400 mol/L MG. so that the plasma level of MG becomes approximately
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Fig. 5. Phosphorylation of MKK3/MKK6 by
methylglyoxal (MG) in rat mesangial cells. Phos-
phorylated MKK3/MKK6 and total MKK3/
MKK6 in rat mesangial cells were determined
by immunoblot analysis. (A) Time-course of
the phosphorylation of MKK3/MKK6 by 400
mol/L MG showed that the peak of the phos-
phorylation occurred at 0.5 hour post-stimula-
tion without a change in total protein content.
(B) MKK3/MKK6 was phosphorylated by in-
cubation with MG for 0.5 hour in a dose-
dependent manner. Incubation for 0.5 hour
with either aminoguanidine (AG) (C ) or
N-acetyl-l-cysteine (NAC) (D), inhibited the
MG (400 mol/L)-induced MKK3/MKK6
phosphorylation. The ratios of phosphorylated
fractions to total MKK3/MKK6 were calcu-
lated respectively from the quantified intensities
of the bands using NIH image. Similar results
were obtained in two independent experiments.
200 nmol/L in diabetic rats [11] and patients [12, 13]. It It has been suggested that MG plays a role in the
pathologic changes in diabetic tissues as a potent precur-has also been reported that the concentration of MG in
blood reached concentrations of 2 mol/L in certain sor for several AGEs, including argpyrimidine [5, 41],
carboxyethyllysine [6], and methylglyoxal-lysine dimercases of diabetes [14]. Although the MG concentration
used in the present experiments was higher than plasma [7]. In addition, recent studies have raised the possibility
that MG directly affects cell functions, contributing tolevels, it may be anticipated that even lower concentra-
tion of MG might cause cellular injuries by incubating for the development of diabetic complications. For example,
MG has been reported to affect cell cycle in certain typeslonger periods. For example, 100 mol/L MG induced
apoptosis in rat mesangial cells at 16 hours, but not of cells [42, 43]. Attempts have been made to harness
this cytotoxic action of MG for use in antiproliferativeat 4 hours. Since the extent of the activation of the
intracellular signaling pathways in response to the lower chemotherapy for neoplasia [43–45]. Furthermore, the
cell death induced by MG appeared to be due to apopto-dose of MG is less, the longer incubation may be required
for the execution of apoptosis. Furthermore, the deduced sis in a variety of cells [42, 43, 46, 47]. However, the
precise mechanism by which MG induced apoptotic cellintracellular concentration of MG in this study may be
comparable to that in vivo for the following reasons. death remained unclear.
Our findings proved that MG-induced apoptosis closelyFirst, it was reported that only 1.8% of the exogenous
MG was taken into cells [15]. Second, it has been re- paralleled activation of p38 MAPK, a member of MAPK
superfamily, in rat mesangial cells. The activation of p38ported that MG level in the kidney tissue is about sixfold
higher than that in plasma [11], probably because glucose MAPK has been reported to mediate apoptosis induced
by cellular stresses, including inflammatory cytokines,was passively incorporated to the cells through insulin-
independent transporter such as glucose transporter-1 growth factor depletion, ultraviolet irradiation, and chem-
ical agents in various types of cells [25–30]. Recent inves-(GLUT-1) and constantly converted to MG in situ [40].
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Fig. 6. Phosphorylation of p38 mitogen-activated pro-
tein kinase (MAPK) by methylglyoxal (MG) in rat
mesangial cells. Phosphorylated p38 MAPK and total
p38 MAPK in rat mesangial cells were determined by
immunoblot analysis. (A) Time-course of the phos-
phorylation of p38 MAPK by 400 mol/L MG showed
that the peak of the phosphorylation occurred at 1
hour post-stimulation without change in total protein
content. (B) p38 MAPK was phosphorylated by incu-
bation with MG for 1 hour in a dose-dependent man-
ner. Aminoguanidine (AG) inhibited the MG (400
mol/L)-induced phosphorylation of p38 MAPK. (C )
N-acetyl-l-cysteine (NAC) inhibited the MG (400
mol/L)-induced p38 MAPK phosphorylation at the
incubation period of 1 hour. (D) SB203580, a specific
inhibitor of p38 MAPK, was also confirmed to inhibit
the MG (400 mol/L)-induced phosphorylation of p38
MAPK. However, SB202474, a negative control, failed
to cause inhibition. Similar results were obtained in
three independent experiments. (E) Time-course of
the p38 MAPK phosphorylation by 100 mol/L MG
was also examined, showing a shorter duration of its
phosphorylation compared with that by 400 mol/L
MG. The ratios of phosphorylated fractions to total
p38 MAPK were calculated respectively from the
quantified intensities of the bands using NIH image.
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Fig. 7. Activation of p38 mitogen-activated
protein kinase (MAPK) by methylglyoxal
(MG) in rat mesangial cells. Immunocomplex
kinase assay for p38 MAPK was carried out.
The activity of p38 MAPK was evaluated by
an ability to phosphorylate exogenously added
activating transcription factor-2 (ATF-2), a
substrate of p38 MAPK, that was detected
by immunoblotting with antiphospho-ATF-2
antibody. The intensities of the bands reflecting
the p38 MAPK activity were quantified using
NIH image. (A) Time-course of the activation
of p38 MAPK by 400 mol/L MG showed
that the peak of the activation occurred at 2
hours post-stimulation. (B) Activation of p38
MAPK was observed by incubation with MG
for 2 hours in a dose-dependent manner.
Aminoguanidine (AG) inhibited the MG (400
mol/L)-induced activation of p38 MAPK.
N-acetyl-l-cysteine (NAC) (C ) and SB203580
(D) inhibited the MG (400 mol/L)-induced
p38 MAPK activation at the incubation period
of 2 hours. Similar results were obtained in
three independent experiments.
Fig. 8. Isoform-dependent phosphorylation of
p38 mitogen-activated protein kinase (MAPK)
by methylglyoxal (MG) in rat mesangial cells.
Rat mesangial cells were incubated with MG
(400mol/L) in the presence and absence of the
inhibitors [aminoguanidine (AG; 400 mol/L),
N-acetyl-l-cysteine (NAC; 20 mmol/L) or SB-
203580 (10 mol/L)] for 1 hour, followed by
immunoprecipitation with anti-p38 or anti-
p38 antibodies. The extent of phosphoryla-
tion in each pellet was evaluated by immuno-
blotting with antiphospho-p38 MAPK antibody.
The ratios of phosphorylated fractions to total
p38 or p38were calculated respectively from
the quantified intensities of the bands using
NIH image. (A) Phosphorylation of p38 iso-
form was induced by MG, and could be sup-
pressed by AG, NAC, and SB SB203580. (B)
Phosphorylation of p38 isoform was induced
little by MG. Similar results were obtained in
two independent experiments.
tigations have indicated that apoptosis signal-regulating MKK3/MKK6, a direct downstream molecule of ASK1,
suggesting an occurrence of ASK1 activation. It has alsokinase 1 (ASK1) plays an important role in mediating
cellular stresses and apoptosis through activation of the been postulated that thioredoxin, a redox-regulatory
protein, is involved in the activation of ASK1. Saitoh et alp38 MAPK and/or JNK pathways [47–49]. The present
study also showed that MG induced phosphorylation of [50] showed that ASK1 was activated when thioredoxin
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was converted to an oxidative form by intracellular re- cells at the advanced stage of various types of glomerulo-
sclerosis [21–24]. For example, Sugiyama et al [21] showedactive oxygen species. They also showed that N-acetyl-
l-cysteine inhibited ASK1 activation, as well as apoptosis that apoptosis occurred in mesangial cells in the glomeru-
losclerotic lesion of the remnant kidney of a 5/6 nephrec-induced by hydrogen peroxide thorough redox-regula-
tory mechanism of thioredoxin. In this regard, it has tomized rat model. The reported apoptosis was marked
after the early transient cell proliferation, leading to thebeen demonstrated that exposure of cells to high con-
centrations of MG causes augmentation of intracellular establishment of sclerotic change in glomerulus. Although
further studies are required to clarify an association ofoxidative stress, probably due to production of reactive
oxygen species during the reaction of MG with intra- apoptosis with the pathogenesis of diabetic glomerulo-
sclerosis, similar mechanisms are expected to be involvedcellular proteins [51–53] and/or to deterioration of anti-
reactive oxygen species enzymes when modified by MG considering the comparable resultant pathologic changes.
[15, 46]. The induction of intracellular oxidative stress
by MG may lead to the activations of ASK1 and its down-
CONCLUSION
stream molecules. In fact, it was reported that MG in-
In conclusion, we found that MG caused sufficientduced the ASK1 activation through reactive oxygen spe-
cellular stress to induce apoptosis through the activationcies generation in Jurkat cells [47]. The present results
of p38 MAPK in rat mesangial cells and to suggest ashowing inhibitory effects of N-acetyl-l-cysteine on the
potential role for MG in the development of diabeticMG-induced activation of the p38 MAPK pathway may
glomerulosclerosis. These results may serve as a novelalso support this hypothesis. Since N-acetyl-l-cysteine has
insight into the therapeutic strategies for diabetic ne-been postulated to act as a pro-oxidant under certain con-
phropathy.ditions through generating thiyl radicals [54], we need to
cautiously interpret the results obtained by using N-acetyl-
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